Growth Metrics

Eledon Pharmaceuticals (ELDN) Cash from Operations Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 74.39%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 158.60%
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn - -40.80%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -40.80%
Dec 31, 2025 25.79%
Sep 30, 2025 -23.01%
Jun 30, 2025 -127.85%
Mar 31, 2025 -83.73%
Dec 31, 2024 -107.94%
Sep 30, 2024 3.93%
Jun 30, 2024 5.44%
Mar 31, 2024 11.92%
Dec 31, 2023 3.68%
Sep 30, 2023 -168.02%
Jun 30, 2023 -32.23%
Mar 31, 2023 -21.68%
Dec 31, 2022 -2.95%
Sep 30, 2022 35.56%
Jun 30, 2022 16.51%
Mar 31, 2022 -57.88%
Dec 31, 2021 2.39%
Sep 30, 2021 -1,164.35%
Jun 30, 2021 -146.47%
Mar 31, 2021 -135.14%
Dec 31, 2020 -366.29%
Sep 30, 2020 80.58%
Jun 30, 2020 38.62%
Mar 31, 2020 45.39%
Dec 31, 2019 39.67%
Sep 30, 2019 1.57%
Jun 30, 2019 -47.63%
Mar 31, 2019 -77.15%
Dec 31, 2018 -28.42%
Sep 30, 2018 14.11%
Jun 30, 2018 58.49%
Mar 31, 2018 -157.48%
Dec 31, 2017 -103.67%
Sep 30, 2017 -131.03%
Jun 30, 2017 -205.98%
Mar 31, 2017 90.94%
Dec 31, 2016 85.56%
Sep 30, 2016 85.57%
Jun 30, 2016 168.86%
Mar 31, 2016 12.28%
Dec 31, 2015 -37.41%
Sep 30, 2015 -129.61%
Jun 30, 2015 -103.01%
Mar 31, 2015 -132.50%
Dec 31, 2014 5.29%